Showing 1401-1410 of 9428 results for "".
DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with AvitDERM2021: The Right Meeting For All Derm PAs/NPs
https://practicaldermatology.com/series/dermatology-education-foundation/derm2021-the-right-meeting-for-all-derm-pasnps/19964/Kristine Kucera, PA-C, MPAS, DHS says all dermatology physician assistants and nurse practitioners should be attending this year’s DERM2021 NP/PA CME Conference. She discusses the unique educational opportunities and access to top-notch presenters available at this meeting.Seeing the Individual in AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/seeing-the-individual-in-ad-care/19890/The best care for patients with atopic dermatitis requires a holistic approach, suggests Dr. Stephan Weidinger. He discusses strategies to improve the management of this complex diseases and highlights innovative strategies for care identified through the Quality of Care in Atopic Dermatitis initiatLearn More About REVIAN® Red Hair Growth System
https://practicaldermatology.com/topics/hair-nails/learn-more-about-revian-red-hair-growth-system/19750/Discover a new option for hair loss patients! REVIAN Red is a patented dual-band LED wireless cap for at-home use ten minutes daily. Click Here to Become a REVIAN Red Professional. REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth in males who have Norwood-Hamilton clDermWireTV: AbbVie to Acquire Allergan, Duobrii Launches, SDPA at 25
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abbvie-to-acquire-allergan-duobrii-launches-sdpa-at-25/19629/In a deal with an equity value of approximately $63 billion, AbbVie has agreed to acquire Allergan. The new company is positioned for new growth platforms and a diversified revenue base; the deal will be immediately accretive to earnings per share, AbbVie says. The Society of Dermatology Physician AAll in One
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/all-in-one/18726/The Sciton Joule platform offers multiple treatment options to address multiple indications in a single, scalable system, making it a top laser platform pick for 2017, says Dr. Cohen during Cosmetic Surgery Forum.Pico Pick-up: Expanding Applications
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pico-pick-up-expanding-applications/18555/What started as a revolutionary approach to removing tattoos, is finding new applications for facial rejuvenation. The expanding use of picosecond technology is making the investment more attractive for aesthetically-focused practices, notes Dr. Gold.Differin Goes OTC, ISDIN Comes to America, Understand AD
https://practicaldermatology.com/topics/psoriasis/dermwiretv-differin-goes-otc-isdin-comes-to-america-understand-ad/18762/Barcelona-based ISDIN is officially operating in the US. The company—which operates in Europe, Latin America, and Asia—is bringing its skincare products to the US market. Regeneron Pharmaceuticals, Sanofi Genzyme, the National Eczema Association, and the Dermatology Nurses Association launch UnderVanquish Approved for Circumferential Fat Reduction; Acquisition News
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-vanquish-approved-for-circumferential-fat-reduction-acquisition-news/18884/BTL's Vanquish Cleared for Circumferential Fat Reduction of the Abdomen, Filler Injections Gain Popularity Off the Face, Protein Linked to Aggressive Melanomas, and new acquisitions at Kythera, Lumenis, XTRAC.ASDS BCC Recommendations; Bad Online Reviews for Derms
https://practicaldermatology.com/topics/practice-management/dermwiretv-asds-bcc-recommendations-bad-online-reviews-for-derms/18906/This edition of DermWireTV, from the editors of Practical Dermatology® magazine reviews the new ASDS Consensus Recommendation for the management of Basal Cell Carcinoma (BCC). An expert panel found Mohs micrographic surgery is highly cost effective. In other news, researchers find that dermatologist